Nitric Oxide Synthase Type II
"Nitric Oxide Synthase Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.
| Descriptor ID |
D052247
|
| MeSH Number(s) |
D08.811.682.664.500.772.500 D12.776.157.687.575 D12.776.660.720.575
|
| Concept/Terms |
Nitric Oxide Synthase Type II- Nitric Oxide Synthase Type II
- Inducible NOS Protein
- NOS-II
- NOS II
- Nitric Oxide Synthase II
- Nitric Oxide Synthase, Type II
- Inducible Nitric Oxide Synthase
- INOS Enzyme
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Synthase Type II".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Synthase Type II".
This graph shows the total number of publications written about "Nitric Oxide Synthase Type II" by people in this website by year, and whether "Nitric Oxide Synthase Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 3 | 4 |
| 2009 | 2 | 3 | 5 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitric Oxide Synthase Type II" by people in Profiles.
-
Curative efficacy of purified serine protease inhibitor PTF3 from potato tuber in experimental visceral leishmaniasis. Int Immunopharmacol. 2020 Aug; 85:106623.
-
Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods Mol Biol. 2018; 1742:265-276.
-
TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors. Retina. 2017 Jan; 37(1):22-31.
-
Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 2017 04; 31(4):1434-1448.
-
Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma. Int J Cancer. 2016 Dec 15; 139(12):2838-2849.
-
STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015 Dec; 83(12):4513-27.
-
Ethanol plus the Jo2 Fas agonistic antibody-induced liver injury is attenuated in mice with partial ablation of argininosuccinate synthase. Alcohol Clin Exp Res. 2014 Mar; 38(3):649-56.
-
Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival. J Pharmacol Exp Ther. 2013 Nov; 347(2):346-56.
-
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia. 2012 Sep; 14(9):778-87.
-
Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. Am J Surg. 2012 Apr; 203(4):428-35.